Volume 86, Issue 4 pp. 768-772
Valvular and Structural Heart Diseases

Critical aortic stenosis and acute ascending aortic penetrating ulcer managed utilizing transapical TAVR and TEVAR

Keith B. Allen MD

Corresponding Author

Keith B. Allen MD

Department of Cardiothoracic Surgery, St. Luke's Mid America Heart Institute, Kansas City, Missouri

Correspondence to: Keith B. Allen, MD, 4320 Wornall Road, Medical Plaza II, Suite 50, Kansas City, MO 64111. E-mail: [email protected]Search for more papers by this author
J. Russell Davis MD

J. Russell Davis MD

Department of Cardiothoracic Surgery, St. Luke's Mid America Heart Institute, Kansas City, Missouri

Search for more papers by this author
David J. Cohen MD

David J. Cohen MD

Department of Cardiology, St. Luke's Mid America Heart Institute, Kansas City, Missouri

Search for more papers by this author
First published: 09 January 2015
Citations: 8

Conflict of interest: Institutional Research Support from Medtronic and Edwards for TAVR trial participation.

Abstract

Thoracic endovascular aortic repair (TEVAR) of acute ascending aortic pathology is feasible; however, the unique features of this aortic segment in addition to access challenges restricts its use to a select, high-risk subset of patients. With the advent of TAVR, large device delivery using transapical access has become a well-defined technique. We report a patient with critical aortic stenosis and an acute ascending aortic penetrating ulcer with tamponade managed successfully utilizing transapical TAVR and TEVAR. To our knowledge, this is the first reported case of a hybrid single-stage TAVR and ascending aortic TEVAR using transapical access. © 2015 Wiley Periodicals, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.